LaunchWorks CDMO

LaunchWorks CDMO

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

LaunchWorks CDMO is a specialized contract development and manufacturing organization (CDMO) serving the molecular diagnostics and broader life sciences sectors. The company offers a full-service model encompassing design and development, technology transfer, precision manufacturing under cGMP/ISO 13485, and final fulfillment and storage. Its primary clientele includes startup innovators, high-volume kitting organizations, and companies facing technical roadblocks in scaling production. As a private, revenue-generating services firm, LaunchWorks aims to accelerate the path to market for diagnostic products by acting as an extension of its clients' operations.

Drug DeliveryBiologics

Technology Platform

Integrated CDMO services for diagnostics: Design & Development, Technology Transfer, cGMP/ISO 13485 Manufacturing (formulation, filling, kitting), and Fulfillment & Storage. Expertise in complex formats like microfluidics and lab-on-chip.

Opportunities

Strong growth in molecular diagnostics, precision medicine, and point-of-care testing drives demand for specialized manufacturing partners.
The company's niche focus and Boston-area location provide access to a dense pipeline of innovative life science startups and established diagnostic firms looking to outsource.

Risk Factors

Faces significant client concentration and competitive risks in the crowded CDMO landscape.
Operational execution risks include supply chain disruptions and complex manufacturing processes, while regulatory compliance failures could severely damage reputation and client trust.

Competitive Landscape

Operates in the competitive CDMO sector, competing with large global players (e.g., Catalent, Lonza) and smaller niche CDMOs. Its differentiation lies in a specialized focus on molecular diagnostics and complex kit manufacturing, as opposed to broader therapeutic manufacturing, and its strategic location in a major biotech hub.